3rd Circ. Told GSK Violated Avandia Warranty
A plaintiff's attorney on Monday asked the Third Circuit to revive a putative class action accusing GlaxoSmithKline PLC of violating the warranty on its diabetes drug Avandia, arguing that contrary to...To view the full article, register now.
Already a subscriber? Click here to view full article